Fragment-Based Drug Discovery
From Proteopedia
(Difference between revisions)
| Line 42: | Line 42: | ||
Using this acylsulfonamide-based ligand as a template, or pharmacophore, other drugs can be designed to have similar effects. <scene name='Sandbox_reserved_394/Abt-737/1'>ABT-737</scene> has been shown to effectively inhibit the over-expression of this protein thereby inducing tumor regression and increasing chemo-sensitivity. | Using this acylsulfonamide-based ligand as a template, or pharmacophore, other drugs can be designed to have similar effects. <scene name='Sandbox_reserved_394/Abt-737/1'>ABT-737</scene> has been shown to effectively inhibit the over-expression of this protein thereby inducing tumor regression and increasing chemo-sensitivity. | ||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
| - | |||
== References == | == References == | ||
{{Reflist}} | {{Reflist}} | ||
Revision as of 18:29, 3 October 2012
Apoptosis by Inhibition of Bcl-2 Family Proteins
| |||||||||||
ABT-737
Using this acylsulfonamide-based ligand as a template, or pharmacophore, other drugs can be designed to have similar effects. has been shown to effectively inhibit the over-expression of this protein thereby inducing tumor regression and increasing chemo-sensitivity.
References
- ↑ Oltersdorf T., Elmore S.W., Shoemaker A.R. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Vol 435|2 June 2005|doi:10.1038/nature03579
